GO Girls welcomes the NICE decision to recommend the use of a new cancer drug which provides a treatment option for patients with a common and aggressive form of advanced endometrial cancer (cancer of the womb lining).
The decision has been announced by the National Institute for Health and Care Excellence (NICE) to issue a final appraisal determination (FAD) recommending the use of JEMPERLI®▼ (dostarlimab) via the Cancer Drugs Fund (CDF).
To date, beyond chemotherapy, there have been limited treatment options for women with advanced, recurrent endometrial cancer in England. Now patients whose cancer has a specific abnormality called MSI-H or MMR deficiency have the opportunity to access immunotherapy with dostarlimab. This is a step forward in improving outcomes for women with endometrial cancer by delivering tailored treatment.
Hilary Maxwell, Chair of GO Girls said: “GO Girls were delighted to be part of the NICE process to advocate the importance of choice in advanced endometrial cancer. Endometrial cancer is the most commonly diagnosed gynaecological cancer in the UK, and the 7th most common cause of cancer death in the UK. This positive outcome is the beginning of wider progress in the treatment and care of people affected by this devastating cancer.”
The prognosis for patients diagnosed with advanced/recurrent endometrial cancer is extremely poor and for those with advanced cancer, there are still relatively few treatment options that can improve their lives or prognosis.
Hilary added “This is the start of precision medicine in this disease.”
GO Girls formed in 2018 to support all women with gynaecological cancers (endometrial or womb – the most common, ovarian – historically referred to as the “silent killer”, cervical, vulval and vaginal). Since its inception, the charity has grown significantly with 750 members across the UK, and is supported by its Patron, Helen Lederer, one of Britain’s best known faces in the field of comedy, writing and acting.
More information here: www.gogirlssupport.org
Hilary Maxwell, CEO & Chair of GO Girls